PEDIATRICS Vol. 107 No. 6 June 2001, pp. 1329-1334
Received Apr 13, 2000; accepted Sep 20, 2000.
,
, §,
, §,
, §,
,
,
, and
From the * Department of Orthopedics and Pediatrics, University
of Louisville School of Medicine, Louisville, Kentucky; Objectives. It has been hypothesized
that Legg-Perthes disease is caused by repeated vascular interruptions
of the blood supply to the proximal femur, which are precipitated by
coagulation system abnormalities. To test this theory, we conducted a
case-control study among 57 patients with Legg-Perthes disease and an
equal number of community controls. We measured protein C and protein S
and resistance to activated protein C (APC-R) from plasma.
Study Design. Participants were placed into 1 of 3 mutually exclusive categories based on the control distribution: 1)
normal, defined as either above or within 1 standard deviation below
the expected mean; 2) low normal, defined as between 1 and 2 standard
deviations below the expected mean; and 3) low, defined as >2 standard
deviations below the expected mean. DNA was analyzed to determine the
presence of a point mutation in the factor V gene that causes APC-R.
Results. We observed a statistically significant increased
risk of Legg-Perthes disease with decreasing levels of protein C
and a nearly significant increased risk with decreasing levels of
protein S. The factor V gene defect was present in 5 (9%) of 55 cases
and 3 (5%) of 56 controls (odds ratio 1.8, 95% confidence interval: 0.4-7.7), but the mean level on the APC-R plasma test was similar for
cases and controls. Nine cases and 1 control had 2 low normal or low
test results (odds ratio 13.0, 95% confidence interval: 2.2-75).
Conclusions. Our results support the belief that
abnormalities of the coagulation system leading to a thrombophilic
state play a role in Legg-Perthes disease; however, larger studies are
needed before definitive recommendations for coagulation testing can be
made.
Hematologic
Diseases Branch, Division of AIDS, STD, and Laboratory Research,
National Center for Infectious Diseases, Centers for Disease Control
and Prevention, US Department of Health and Human Services, Atlanta,
Georgia; § Department of Epidemiology, Rollins School of Public Health,
Emory University, Atlanta, Georgia; and
Emory University School of
Medicine, Atlanta, Georgia.
This article has been cited by other articles:
![]() |
C. J. Glueck, R. A. Freiberg, S. Boppana, and P. Wang Thrombophilia, Hypofibrinolysis, the eNOS T-786C Polymorphism, and Multifocal Osteonecrosis J. Bone Joint Surg. Am., October 1, 2008; 90(10): 2220 - 2229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Glueck, R. A. Freiberg, J. Oghene, R. N. Fontaine, and P. Wang Association Between the T-786C eNOS Polymorphism and Idiopathic Osteonecrosis of the Head of the Femur J. Bone Joint Surg. Am., November 1, 2007; 89(11): 2460 - 2468. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Balasa, R. A. Gruppo, C. J. Glueck, P. Wang, D. R. Roy, E. J. Wall, C. T. Mehlman, and A. H. Crawford Legg-Calve-Perthes Disease and Thrombophilia J. Bone Joint Surg. Am., December 1, 2004; 86(12): 2642 - 2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Hresko, P. A. McDougall, J. B. Gorlin, E. C. Vamvakas, J. R. Kasser, and E. J. Neufeld Prospective Reevaluation of the Association Between Thrombotic Diathesis and Legg-Perthes Disease J. Bone Joint Surg. Am., September 3, 2002; 84(9): 1613 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gaughan, L. M. Mofenson, M. D. Hughes, G. R. Seage III, G. L. Ciupak, and J. M. Oleske Osteonecrosis of the Hip (Legg-Calve-Perthes Disease) in Human Immunodeficiency Virus-Infected Children Pediatrics, May 1, 2002; 109(5): e74 - 74. [Abstract] [Full Text] [PDF] |
||||